m+Medelevator.RU
← Поиск публикаций
The Canadian journal of cardiology · 2012

The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

СтатьяПоддержка исследования: вне правительства СШАОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Daskalopoulou Stella S, Khan Nadia A, Quinn Robert R, Ruzicka Marcel, McKay Donald W, Hackam Daniel G, Rabkin Simon W, Rabi Doreen M, Gilbert Richard E, Padwal Raj S, Dawes Martin, Touyz Rhian M, Campbell Tavis S, Cloutier Lyne, Grover Steven, Honos George, Herman Robert J, Schiffrin Ernesto L, Bolli Peter, Wilson Thomas, Feldman Ross D, Lindsay M Patrice, Hemmelgarn Brenda R, Hill Michael D, Gelfer Mark, Burns Kevin D, Vallée Michel, Prasad G V Ramesh, Lebel Marcel, McLean Donna, Arnold J Malcolm O, Moe Gordon W, Howlett Jonathan G, Boulanger Jean-Martin, Larochelle Pierre, Leiter Lawrence A, Jones Charlotte, Ogilvie Richard I, Woo Vincent, Kaczorowski Janusz, Trudeau Luc, Bacon Simon L, Petrella Robert J, Milot Alain, Stone James A, Drouin Denis, Lamarre-Cliché Maxime, Godwin Marshall, Tremblay Guy, Hamet Pavel, Fodor George, Carruthers S George, Pylypchuk George, Burgess Ellen, Lewanczuk Richard, Dresser George K, Penner Brian, Hegele Robert A, McFarlane Philip A, Sharma Mukul, Campbell Norman R C, Reid Debra, Poirier Luc, Tobe Sheldon W, Canadian Hypertension Education Program

Аннотация

We updated the evidence-based recommendations for the diagnosis, assessment, prevention, and treatment of hypertension in adults for 2012. The new recommendations are: (1) use of home blood pressure monitoring to confirm a diagnosis of white coat syndrome; (2) mineralocorticoid receptor antagonists may be used in selected patients with hypertension and systolic heart failure; (3) a history of atrial fibrillation in patients with hypertension should not be a factor in deciding to prescribe an angiotensin-receptor blocker for the treatment of hypertension; and (4) the blood pressure target for patients with nondiabetic chronic kidney disease has now been changed to < 140/90 mm Hg from < 130/80 mm Hg. We also reviewed the recent evidence on blood pressure targets for patients with hypertension and diabetes and continue to recommend a blood pressure target of less than 130/80 mm Hg.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты